Phosphodiesterase 4B activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and cAMP/PKA/p-CREB/PGC-1α signaling

Proliferation of smooth muscle cells, oxidative stress, and pulmonary vasoconstriction resulting from intermittent hypoxia (IH) facilitate pulmonary hypertension (PH) in patients with obstructive sleep apnea. The role of Phosphodiesterase 4 B (PDE4B) in PH has not yet been established. Herein, we in...

Full description

Bibliographic Details
Main Authors: Zhou Pan, Xiaofeng Wu, Xinyue Zhang, Ke Hu
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332222014846
_version_ 1811177300033536000
author Zhou Pan
Xiaofeng Wu
Xinyue Zhang
Ke Hu
author_facet Zhou Pan
Xiaofeng Wu
Xinyue Zhang
Ke Hu
author_sort Zhou Pan
collection DOAJ
description Proliferation of smooth muscle cells, oxidative stress, and pulmonary vasoconstriction resulting from intermittent hypoxia (IH) facilitate pulmonary hypertension (PH) in patients with obstructive sleep apnea. The role of Phosphodiesterase 4 B (PDE4B) in PH has not yet been established. Herein, we investigated whether PDE4B inhibition ameliorates experimental PH by modulating cAMP signaling. We performed an integrative analysis of PDE4B expression in Gene Expression Omnibus datasets, experimental IH-induced rat PH samples, and IH-induced pulmonary arterial smooth muscle cells (PASMCs). PDE4B expression was modulated using siRNA in vitro and a specific adeno-associated virus serotype 1 in vivo. In the databases of mouse models of IH-induced and sustained hypoxia-induced PH and in a rat model of six weeks of IH, the expression of PDE4B was up-regulated. Inhibition of PDE4B attenuated IH-induced pulmonary vascular remodeling and right ventricular hypertrophy. Our results also showed that PDE4B deficiency inhibited IH-induced proliferation of PASMCs with less mitochondrial reactive oxygen species and mitochondrial damage. Meanwhile, IH induced an increase in ATF4, which positively regulated the expression of PDE4B through transcription, and inhibition of ATF4 exerted effects similar to those of PDE4B inhibition. Mechanistically, downregulating the expression of PDE4B resulted in the activation of the cAMP/PKA/p-CREB/PGC-1α pathway in PASMCs after IH. Taken together, our present study provides evidence that inhibition of PDE4B attenuates IH-induced PH by regulating cAMP signaling.
first_indexed 2024-04-10T22:59:29Z
format Article
id doaj.art-bf9bed8c66094276b0ae887d00a820c2
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-04-10T22:59:29Z
publishDate 2023-02-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-bf9bed8c66094276b0ae887d00a820c22023-01-14T04:25:43ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-02-01158114095Phosphodiesterase 4B activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and cAMP/PKA/p-CREB/PGC-1α signalingZhou Pan0Xiaofeng Wu1Xinyue Zhang2Ke Hu3Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, ChinaDepartment of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, ChinaDepartment of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, ChinaCorresponding author.; Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, ChinaProliferation of smooth muscle cells, oxidative stress, and pulmonary vasoconstriction resulting from intermittent hypoxia (IH) facilitate pulmonary hypertension (PH) in patients with obstructive sleep apnea. The role of Phosphodiesterase 4 B (PDE4B) in PH has not yet been established. Herein, we investigated whether PDE4B inhibition ameliorates experimental PH by modulating cAMP signaling. We performed an integrative analysis of PDE4B expression in Gene Expression Omnibus datasets, experimental IH-induced rat PH samples, and IH-induced pulmonary arterial smooth muscle cells (PASMCs). PDE4B expression was modulated using siRNA in vitro and a specific adeno-associated virus serotype 1 in vivo. In the databases of mouse models of IH-induced and sustained hypoxia-induced PH and in a rat model of six weeks of IH, the expression of PDE4B was up-regulated. Inhibition of PDE4B attenuated IH-induced pulmonary vascular remodeling and right ventricular hypertrophy. Our results also showed that PDE4B deficiency inhibited IH-induced proliferation of PASMCs with less mitochondrial reactive oxygen species and mitochondrial damage. Meanwhile, IH induced an increase in ATF4, which positively regulated the expression of PDE4B through transcription, and inhibition of ATF4 exerted effects similar to those of PDE4B inhibition. Mechanistically, downregulating the expression of PDE4B resulted in the activation of the cAMP/PKA/p-CREB/PGC-1α pathway in PASMCs after IH. Taken together, our present study provides evidence that inhibition of PDE4B attenuates IH-induced PH by regulating cAMP signaling.http://www.sciencedirect.com/science/article/pii/S0753332222014846Chronic intermittent hypoxiaPulmonary hypertensionPDE4BcAMPATF4
spellingShingle Zhou Pan
Xiaofeng Wu
Xinyue Zhang
Ke Hu
Phosphodiesterase 4B activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and cAMP/PKA/p-CREB/PGC-1α signaling
Biomedicine & Pharmacotherapy
Chronic intermittent hypoxia
Pulmonary hypertension
PDE4B
cAMP
ATF4
title Phosphodiesterase 4B activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and cAMP/PKA/p-CREB/PGC-1α signaling
title_full Phosphodiesterase 4B activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and cAMP/PKA/p-CREB/PGC-1α signaling
title_fullStr Phosphodiesterase 4B activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and cAMP/PKA/p-CREB/PGC-1α signaling
title_full_unstemmed Phosphodiesterase 4B activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and cAMP/PKA/p-CREB/PGC-1α signaling
title_short Phosphodiesterase 4B activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and cAMP/PKA/p-CREB/PGC-1α signaling
title_sort phosphodiesterase 4b activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and camp pka p creb pgc 1α signaling
topic Chronic intermittent hypoxia
Pulmonary hypertension
PDE4B
cAMP
ATF4
url http://www.sciencedirect.com/science/article/pii/S0753332222014846
work_keys_str_mv AT zhoupan phosphodiesterase4bactivationexacerbatespulmonaryhypertensioninducedbyintermittenthypoxiabyregulatingmitochondrialinjuryandcamppkapcrebpgc1asignaling
AT xiaofengwu phosphodiesterase4bactivationexacerbatespulmonaryhypertensioninducedbyintermittenthypoxiabyregulatingmitochondrialinjuryandcamppkapcrebpgc1asignaling
AT xinyuezhang phosphodiesterase4bactivationexacerbatespulmonaryhypertensioninducedbyintermittenthypoxiabyregulatingmitochondrialinjuryandcamppkapcrebpgc1asignaling
AT kehu phosphodiesterase4bactivationexacerbatespulmonaryhypertensioninducedbyintermittenthypoxiabyregulatingmitochondrialinjuryandcamppkapcrebpgc1asignaling